Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""immunology"" wg kryterium: Temat


Tytuł :
Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI).
Autorzy :
Knight V; Department of Pediatrics and Children's Hospital, University of Colorado School of Medicine, Aurora, CO, United States of America. Electronic address: .
Askar MZ; Baylor University Medical Center, Dallas, TX, United States of America.
Ntrivalas E; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.
Nandiwada SL; Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States of America.
Peterson LK; ARUP Institute for Clinical and Experimental Pathology and Department of Pathology, University of Utah Health, Salt Lake City, UT, United States of America.
Tebo AE; ARUP Institute for Clinical and Experimental Pathology and Department of Pathology, University of Utah Health, Salt Lake City, UT, United States of America.
Kadkhoda K; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, United States of America.
Schmitz JL; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, United States of America.
Naides SJ; Euroimmun US Inc., Mountain Lakes, NJ, United States of America.
Snyder MR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America.
Sadighi Akha AA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Journal of immunological methods [J Immunol Methods] 2021 May; Vol. 492, pp. 112994. Date of Electronic Publication: 2021 Feb 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Allergy and Immunology*
Societies, Medical*
COVID-19/*immunology
Immunotherapy/*methods
SARS-CoV-2/*physiology
Algorithms ; Animals ; Group Processes ; Histocompatibility Testing ; Host-Pathogen Interactions ; Humans ; Laboratories ; Pandemics ; SARS-CoV-2/chemistry ; Transplantation Immunology ; Virtual Reality
Czasopismo naukowe
Tytuł :
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.
Autorzy :
Recchiuti A; Department of Medical, Oral, and Biotechnology Science, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Patruno S; Department of Medical, Oral, and Biotechnology Science, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Mattoscio D; Department of Medical, Oral, and Biotechnology Science, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Isopi E; Department of Medical, Oral, and Biotechnology Science, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Pomilio A; Department of Medical, Oral, and Biotechnology Science, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Lamolinara A; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Department of Neurosciences, Imaging and Clinical Sciences, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Iezzi M; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Department of Neurosciences, Imaging and Clinical Sciences, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Pecce R; Department of Medical, Oral, and Biotechnology Science, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Romano M; Department of Medical, Oral, and Biotechnology Science, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.; Center for Advanced Studies and Technology, Università 'G. d'Annunzio' Chieti - Pescara, Chieti, Italy.
Pokaż więcej
Źródło :
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2021 Apr; Vol. 35 (4), pp. e21441.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/immunology
COVID-19*/microbiology
COVID-19*/pathology
Cystic Fibrosis*/immunology
Cystic Fibrosis*/microbiology
Cystic Fibrosis*/pathology
Cystic Fibrosis*/virology
Macrophages*/immunology
Macrophages*/microbiology
Macrophages*/pathology
Macrophages*/virology
Pseudomonas Infections*/immunology
Pseudomonas Infections*/pathology
Pseudomonas Infections*/virology
Docosahexaenoic Acids/*pharmacology
Pseudomonas aeruginosa/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Cytokines/immunology ; Female ; Gene Expression Regulation/drug effects ; Gene Expression Regulation/immunology ; Humans ; Inflammation/immunology ; Inflammation/microbiology ; Inflammation/pathology ; Inflammation/virology ; Male ; MicroRNAs/immunology
Czasopismo naukowe
Tytuł :
Durable SARS-CoV-2 B cell immunity after mild or severe disease.
Autorzy :
Ogega CO; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Skinner NE; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Blair PW; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Park HS; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Littlefield K; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ganesan A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Dhakal S; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ladiwala P; Advanced Mammalian Biomanufacturing Innovation Center, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
Antar AA; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ray SC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Betenbaugh MJ; Advanced Mammalian Biomanufacturing Innovation Center, Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
Pekosz A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Klein SL; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Manabe YC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cox AL; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Bailey JR; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Apr 01; Vol. 131 (7).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
SARS-CoV-2*/immunology
B-Lymphocytes/*immunology
COVID-19/*immunology
Adult ; Aged ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Binding Sites/immunology ; COVID-19/virology ; Case-Control Studies ; Cohort Studies ; Female ; Humans ; Immunity, Cellular ; Immunoglobulin Class Switching ; Immunologic Memory ; Male ; Middle Aged ; Pandemics ; Severity of Illness Index ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology ; Time Factors
Czasopismo naukowe
Tytuł :
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
Autorzy :
Lu M; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Dravid P; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.
Zhang Y; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Trivedi S; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.
Li A; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Harder O; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Kc M; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.
Chaiwatpongsakorn S; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.
Zani A; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.
Kenney A; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.
Zeng C; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Cai C; Department of Surgery, College of Medicine, The Ohio State University, Columbus, OH 43210.
Ye C; Texas Biomedical Research Institute, San Antonio, TX 78227.
Liang X; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Shimamura M; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH 43210.
Liu SL; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.; Center for Retrovirus Research, The Ohio State University, Columbus, OH 43210.
Mejias A; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH 43210.
Ramilo O; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH 43210.
Boyaka PN; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Qiu J; Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, KS 66160.
Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, TX 78227.
Yount JS; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Peeples ME; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Kapoor A; Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205.; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Niewiesk S; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Li J; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210; .; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Mar 23; Vol. 118 (12).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Vectors*/genetics
Genetic Vectors*/immunology
Measles virus*/genetics
Measles virus*/immunology
COVID-19/*prevention & control
COVID-19 Vaccines/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Vaccines, Synthetic/*immunology
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; COVID-19/complications ; COVID-19/pathology ; COVID-19 Vaccines/genetics ; Cricetinae ; Disease Models, Animal ; Gene Expression ; Humans ; Immunization ; Immunogenicity, Vaccine ; Mice ; Mice, Transgenic ; Rats ; Spike Glycoprotein, Coronavirus/genetics ; Vaccines, Synthetic/genetics
Czasopismo naukowe
Tytuł :
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 T cell responses.
Autorzy :
Agerer B; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Koblischke M; Center for Virology, Medical University of Vienna, Vienna, Austria.
Gudipati V; Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Montaño-Gutierrez LF; St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.
Smyth M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Popa A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Genger JW; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Endler L; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Florian DM; Center for Virology, Medical University of Vienna, Vienna, Austria.
Mühlgrabner V; Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Graninger M; Center for Virology, Medical University of Vienna, Vienna, Austria.
Aberle SW; Center for Virology, Medical University of Vienna, Vienna, Austria.
Husa AM; St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.
Shaw LE; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Lercher A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Gattinger P; Department of Pathophysiology and Allergy Research, Division of Immunopathology, Medical University of Vienna, Vienna, Austria.
Torralba-Gombau R; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Trapin D; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Penz T; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Barreca D; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Fae I; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Wenda S; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Traugott M; Department of Medicine 4, Clinic Favoriten, Vienna, Austria.
Walder G; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Pickl WF; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.; Karl Landsteiner University of Health Sciences, Krems, Austria.
Thiel V; Institute of Virology and Immunology, Bern and Mittelhäusern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Allerberger F; Austrian Agency for Health and Food Safety (AGES), Vienna, Austria.
Stockinger H; Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Puchhammer-Stöckl E; Center for Virology, Medical University of Vienna, Vienna, Austria.
Weninger W; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Fischer G; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Hoepler W; Department of Medicine 4, Clinic Favoriten, Vienna, Austria.
Pawelka E; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Zoufaly A; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Valenta R; Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.; Department of Pathophysiology and Allergy Research, Division of Immunopathology, Medical University of Vienna, Vienna, Austria.; Karl Landsteiner University of Health Sciences, Krems, Austria.; Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, First Moscow State Medical University Sechenov, Moscow, Russia.; NRC Institute of Immunology FMBA of Russia, Moscow, Russia.
Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Paster W; St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.
Geyeregger R; St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.
Farlik M; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Halbritter F; St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.
Huppa JB; Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Aberle JH; Center for Virology, Medical University of Vienna, Vienna, Austria.
Bergthaler A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. .
Pokaż więcej
Źródło :
Science immunology [Sci Immunol] 2021 Mar 04; Vol. 6 (57).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/genetics
COVID-19*/immunology
COVID-19*/pathology
Epitopes, T-Lymphocyte*/genetics
Epitopes, T-Lymphocyte*/immunology
Immunity, Cellular*
Mutation*
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
CD8-Positive T-Lymphocytes/*immunology
HLA-A Antigens/*immunology
CD8-Positive T-Lymphocytes/pathology ; Cell Proliferation ; High-Throughput Nucleotide Sequencing ; Humans ; Interferon-gamma/immunology ; Peptides/genetics ; Peptides/immunology
Czasopismo naukowe
Tytuł :
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
Autorzy :
Bastard P; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Michailidis E; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
Hoffmann HH; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
Chbihi M; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Le Voyer T; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Rosain J; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Philippot Q; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Seeleuthner Y; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.
Gervais A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Materna M; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
de Oliveira PMN; Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
Maia MLS; Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
Dinis Ano Bom AP; Laboratory of Immunological Techniques, Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
Azamor T; Laboratory of Immunological Techniques, Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
Araújo da Conceição D; Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
Goudouris E; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Homma A; Bio-Manguinhos, Fiocruz, Ministry of Health, Rio de Janeiro, Brazil.
Slesak G; Tropical Medicine Department, Tropenklinik Paul-Lechler-Krankenhaus, Tübingen, Germany.
Schäfer J; Tropical Medicine Department, Tropenklinik Paul-Lechler-Krankenhaus, Tübingen, Germany.
Pulendran B; Emory Vaccine Center and the Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.; Institute for Immunity, Transplantation and Infection, Department of Pathology, Department of Microbiology and Immunology, Stanford University, Stanford, CA.
Miller JD; Emory Vaccine Center and the Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.; Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Scientific Resources, Atlanta, GA.
Huits R; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Yang R; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Rosen LB; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Bizien L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Lorenzo L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Chrabieh M; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.
Erazo LV; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.
Rozenberg F; Laboratory of Virology, University of Paris, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Jeljeli MM; Laboratory of Immunology, University of Paris, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Béziat V; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Holland SM; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Cobat A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Su HC; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Ahmed R; Emory Vaccine Center and the Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA.
Puel A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Zhang SY; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Abel L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Seligman SJ; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.; New York Medical College, Valhalla, NY.
Zhang Q; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
MacDonald MR; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
Jouanguy E; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Rice CM; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
Casanova JL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.; Howard Hughes Medical Institute, New York, NY.
Pokaż więcej
Źródło :
The Journal of experimental medicine [J Exp Med] 2021 Apr 05; Vol. 218 (4).
Typ publikacji :
Journal Article
MeSH Terms :
Autoimmune Diseases*/genetics
Autoimmune Diseases*/immunology
COVID-19*/genetics
COVID-19*/immunology
Genetic Diseases, Inborn*/genetics
Genetic Diseases, Inborn*/immunology
Interferon-alpha*/genetics
Interferon-alpha*/immunology
Receptor, Interferon alpha-beta*/deficiency
Receptor, Interferon alpha-beta*/immunology
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
Yellow Fever Vaccine*/adverse effects
Yellow Fever Vaccine*/genetics
Yellow Fever Vaccine*/immunology
Yellow fever virus*/genetics
Yellow fever virus*/immunology
Antibodies, Neutralizing/*immunology
Autoantibodies/*immunology
Adolescent ; Adult ; Aged ; Female ; HEK293 Cells ; Humans ; Male ; Middle Aged ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology
Czasopismo naukowe
Tytuł :
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort.
Autorzy :
Caccuri F; Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Medical School, Brescia, Italy.
Bugatti A; Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Medical School, Brescia, Italy.
Meini A; Pediatrics Clinic, Children's Hospital, ASST Spedali Civili, Brescia, Italy.
Bonfanti C; Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Medical School, Brescia, Italy.
Motta M; Neonatology and Neonatal Intensive Care, Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
Savarè L; Pediatrics Clinic, Children's Hospital, ASST Spedali Civili, Brescia, Italy.
Arrighini A; Pediatric Emergency Department, Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
Bondioni MP; Pediatric Radiology, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Lougaris V; Pediatrics Clinic, Department of Clinical and Experimental Sciences, University of Brescia and Children's Hospital, ASST-Spedali Civili, Brescia, Italy. Electronic address: .
Caruso A; Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Medical School, Brescia, Italy.
Plebani A; Pediatrics Clinic, Department of Clinical and Experimental Sciences, University of Brescia and Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
Pokaż więcej
Źródło :
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2021 Apr; Vol. 225, pp. 108695. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji :
Letter
MeSH Terms :
Host-Pathogen Interactions*/immunology
Viral Load*
Antibodies, Viral/*immunology
COVID-19/*immunology
COVID-19/*virology
Gastrointestinal Tract/*virology
Respiratory System/*virology
SARS-CoV-2/*immunology
Age Factors ; Antibodies, Viral/blood ; COVID-19/epidemiology ; Gastrointestinal Tract/immunology ; Humans ; Italy/epidemiology ; Respiratory System/immunology
Opinia redakcyjna
Tytuł :
A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: An ecological approach.
Autorzy :
Romero-López JP; Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, UNAM, Avenida de los Barrios 1, Tlalnepantla de Baz, Estado de México, Mexico.; Laboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.
Carnalla-Cortés M; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico.
Pacheco-Olvera DL; Laboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.; Unidad Médica de Investigación en Inmunoquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Mexico City, Mexico.
Ocampo-Godínez JM; Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, UNAM, Avenida de los Barrios 1, Tlalnepantla de Baz, Estado de México, Mexico.; Laboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.; Laboratorio de Ingeniería de Tejidos, Posgrado de la Facultad de Odontología, UNAM, Mexico City, Mexico.
Oliva-Ramírez J; Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Mexico City, Mexico.
Moreno-Manjón J; Laboratorio de Infectología, Microbiología e Inmunología Clínicas, Unidad de Investigación en Medicina Experimental, Facultad de Medicina, UNAM, Mexico City, Mexico.; Laboratorio de Bacteriología Médica, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.
Bernal-Alferes B; Laboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.; Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, Mexico.
López-Olmedo N; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico.
García-Latorre E; Laboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.
Domínguez-López ML; Laboratorio de Inmunoquímica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala SN, Mexico City, Mexico.
Reyes-Sandoval A; Nuffield Department of Medicine, The Jenner Institute, The Henry Welcome Building for Molecular Physiology, University of Oxford, Oxford, UK.
Jiménez-Zamudio L; Laboratorio de Inmunología Clínica 1, Posgrado en Ciencias Quimicobiológicas, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Apr; Vol. 93 (4), pp. 2029-2038. Date of Electronic Publication: 2020 Oct 10.
Typ publikacji :
Journal Article
MeSH Terms :
Antigen Presentation*
COVID-19*/immunology
COVID-19*/mortality
HLA-DRB1 Chains/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Computational Biology ; Epitopes, T-Lymphocyte/immunology ; Genetic Variation ; Hospitalization ; Humans ; Mexico ; Protein Structure, Tertiary ; SARS-CoV-2/immunology
Czasopismo naukowe
Tytuł :
Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Autorzy :
Almofti YA; Department of Molecular Biology and Bioinformatics, College of Veterinary Medicine, University of Bahri, Khartoum, Sudan. .
Abd-Elrahman KA; Department of Pharmaceutical Technology, College of Pharmacy, University of Medical Science and Technology (MUST), Khartoum, Sudan.
Eltilib EEM; Department of Molecular Biology and Bioinformatics, College of Veterinary Medicine, University of Bahri, Khartoum, Sudan.
Pokaż więcej
Źródło :
BMC immunology [BMC Immunol] 2021 Mar 25; Vol. 22 (1), pp. 22. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*/chemistry
COVID-19 Vaccines*/genetics
COVID-19 Vaccines*/immunology
Epitopes, B-Lymphocyte*/chemistry
Epitopes, B-Lymphocyte*/genetics
Epitopes, B-Lymphocyte*/immunology
Epitopes, T-Lymphocyte*/chemistry
Epitopes, T-Lymphocyte*/genetics
Epitopes, T-Lymphocyte*/immunology
SARS-CoV-2*/chemistry
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
Spike Glycoprotein, Coronavirus*/chemistry
Spike Glycoprotein, Coronavirus*/genetics
Spike Glycoprotein, Coronavirus*/immunology
Viral Proteins*/chemistry
Viral Proteins*/genetics
Viral Proteins*/immunology
COVID-19/*immunology
B-Lymphocytes/immunology ; COVID-19/prevention & control ; Humans ; Polyproteins/chemistry ; Polyproteins/genetics ; Polyproteins/immunology ; T-Lymphocytes/immunology
Czasopismo naukowe
Tytuł :
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates.
Autorzy :
He L; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Lin X; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Wang Y; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA 19140, USA.; Department of Microbiology and Immunology, Temple University, Philadelphia, PA 19140, USA.
Abraham C; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA 19140, USA.
Sou C; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Ngo T; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Zhang Y; Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA 19140, USA.; Department of Microbiology and Immunology, Temple University, Philadelphia, PA 19140, USA.
Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.; Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Zhu J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. .; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Pokaż więcej
Źródło :
Science advances [Sci Adv] 2021 Mar 19; Vol. 7 (12). Date of Electronic Publication: 2021 Mar 19 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19 Vaccines*/chemistry
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/pharmacology
Nanoparticles*/chemistry
Nanoparticles*/therapeutic use
SARS-CoV-2*/chemistry
SARS-CoV-2*/immunology
Spike Glycoprotein, Coronavirus*/chemistry
Spike Glycoprotein, Coronavirus*/immunology
Spike Glycoprotein, Coronavirus*/pharmacology
COVID-19/*immunology
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; COVID-19/prevention & control ; HEK293 Cells ; Humans ; Immunogenicity, Vaccine ; Mice ; Mice, Inbred BALB C ; Protein Domains
Czasopismo naukowe
Tytuł :
The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
Autorzy :
Soltani S; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
Zakeri A; Department of Hematology, School of Medicine, Tarbiat Modares University, Tehran, Iran.
Zandi M; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
Kesheh MM; Department of Virology, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Tabibzadeh A; Department of Virology, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Dastranj M; Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Faramarzi S; Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Didehdar M; Department of Medical Parasitology and Mycology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Hafezi H; Department of Dermatology, School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Hosseini P; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Farahani A; Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2021 Feb 23; Vol. 2021, pp. 6670798. Date of Electronic Publication: 2021 Feb 23 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*/immunology
COVID-19*/microbiology
Dysbiosis*/immunology
Dysbiosis*/microbiology
Dysbiosis*/virology
Lung*/immunology
Lung*/microbiology
Lung*/virology
Mycobiome/*immunology
SARS-CoV-2/*immunology
Gastrointestinal Microbiome/immunology ; Humans
Czasopismo naukowe
Tytuł :
Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Plasmodium falciparum Infection Be Protective?
Autorzy :
Kalungi A; Mental Health Section of MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.; Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda.; Department of Psychiatry, Faculty of Medicine & Health Sciences, Stellenbosch University, Cape Town, South Africa.
Kinyanda E; Mental Health Section of MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.; Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda.
Akena DH; Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda.
Kaleebu P; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.
Bisangwa IM; ATCG Solutions (Uganda) Limited, Uganda Industrial Research Institute, Kampala, Uganda.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Feb 18; Vol. 12, pp. 565625. Date of Electronic Publication: 2021 Feb 18 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/immunology
Immunologic Memory*
Malaria, Falciparum*/epidemiology
Malaria, Falciparum*/immunology
Basigin/*immunology
Plasmodium falciparum/*immunology
SARS-CoV-2/*immunology
Africa South of the Sahara/epidemiology ; Humans ; Merozoites/immunology ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Obesity, Nutrients and the Immune System in the Era of COVID-19.
Autorzy :
De Bandt JP; Department of Physiology, Faculty of Pharmacy, University of Paris, 75006 Paris, France.
Monin C; Department of Physiology, Faculty of Pharmacy, University of Paris, 75006 Paris, France.
Pokaż więcej
Źródło :
Nutrients [Nutrients] 2021 Feb 13; Vol. 13 (2). Date of Electronic Publication: 2021 Feb 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/immunology
Nutrients*
Obesity*/epidemiology
Obesity*/immunology
SARS-CoV-2/*immunology
Adipose Tissue/immunology ; Cytokines/immunology ; Humans ; Inflammation/epidemiology ; Inflammation/immunology
Czasopismo naukowe
Tytuł :
Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs).
Autorzy :
McCarthy CG; Program in Physiological Genomics, UT Microbiome Consortium, Center for Hypertension & Personalized Medicine, Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Saha P; Program in Physiological Genomics, UT Microbiome Consortium, Center for Hypertension & Personalized Medicine, Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Golonka RM; Program in Physiological Genomics, UT Microbiome Consortium, Center for Hypertension & Personalized Medicine, Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Wenceslau CF; Program in Physiological Genomics, UT Microbiome Consortium, Center for Hypertension & Personalized Medicine, Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Joe B; Program in Physiological Genomics, UT Microbiome Consortium, Center for Hypertension & Personalized Medicine, Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Vijay-Kumar M; Program in Physiological Genomics, UT Microbiome Consortium, Center for Hypertension & Personalized Medicine, Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
Pokaż więcej
Źródło :
Comprehensive Physiology [Compr Physiol] 2021 Feb 12; Vol. 11 (1), pp. 1575-1589. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
COVID-19*/complications
COVID-19*/immunology
Extracellular Traps/*immunology
Hypertension/*immunology
Immunity, Innate/*immunology
Neutrophils/*immunology
Animals ; Gastrointestinal Microbiome/immunology ; Humans ; Hypertension/physiopathology ; Inflammation/immunology ; Inflammation/physiopathology ; Oxidative Stress/immunology ; SARS-CoV-2/immunology
Czasopismo naukowe
Tytuł :
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Autorzy :
Yang Z; Ming Hsieh Department of Electrical and Computer Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Bogdan P; Ming Hsieh Department of Electrical and Computer Engineering, University of Southern California, Los Angeles, CA, 90089, USA. .
Nazarian S; Ming Hsieh Department of Electrical and Computer Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Feb 05; Vol. 11 (1), pp. 3238. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/chemistry
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/toxicity
Deep Learning*
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Allergens ; COVID-19/prevention & control ; Codon Usage ; Computational Biology ; Drug Design ; Epitopes, B-Lymphocyte/immunology ; Epitopes, T-Lymphocyte/immunology ; Humans ; Immunogenicity, Vaccine ; Models, Molecular ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Mutation ; Protein Conformation ; RNA, Viral ; SARS-CoV-2/chemistry ; SARS-CoV-2/genetics ; Solubility ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/genetics ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Helper-Inducer/immunology ; Vaccines, Subunit/chemistry ; Vaccines, Subunit/immunology
Czasopismo naukowe
Tytuł :
COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.
Autorzy :
Goodnow CC; Garvan Institute of Medical Research, Sydney, NSW, Australia.; Cellular Genomics Futures Institute, UNSW Sydney, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Immunology and cell biology [Immunol Cell Biol] 2021 Feb; Vol. 99 (2), pp. 177-191. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*/genetics
COVID-19*/immunology
COVID-19*/virology
Immune Tolerance/*immunology
Immunity, Innate/*genetics
SARS-CoV-2/*immunology
Virus Diseases/*immunology
Adaptive Immunity/genetics ; Adaptive Immunity/immunology ; Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/physiology ; Antibodies, Viral/immunology ; Humans ; Immune Tolerance/genetics ; Rabbits ; SARS-CoV-2/genetics ; Viral Zoonoses/genetics ; Viral Zoonoses/immunology ; Virus Diseases/genetics
Czasopismo naukowe
Tytuł :
Before Virus, After Virus: A Reckoning.
Autorzy :
Mukherjee S; Herbert Irving Cancer Center, Department of Medicine, Division of Oncology, Columbia University School of Medicine, New York, New York, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell [Cell] 2020 Oct 15; Vol. 183 (2), pp. 308-314.
Typ publikacji :
Historical Article; Journal Article; Review
MeSH Terms :
Allergy and Immunology*/history
Immunity*
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Pneumonia, Viral/*immunology
Animals ; Awards and Prizes ; COVID-19 ; Cytokines/immunology ; History, 19th Century ; History, 20th Century ; History, 21st Century ; Humans ; Immune System/cytology ; Immunoglobulins/genetics ; Immunoglobulins/immunology ; Lymphocytes/cytology ; Pandemics ; SARS-CoV-2 ; Vaccination/history
Czasopismo naukowe
Tytuł :
Epithelial response to IFN-γ promotes SARS-CoV-2 infection.
Autorzy :
Heuberger J; Department of Hepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Trimpert J; Institute of Virology, Freie Universität Berlin, Berlin, Germany.
Vladimirova D; Institute of Virology, Freie Universität Berlin, Berlin, Germany.
Goosmann C; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Lin M; Department of Hepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.
Schmuck R; Department of Surgery, Charité University Medicine, Berlin, Germany.
Mollenkopf HJ; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Brinkmann V; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Tacke F; Department of Hepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.
Osterrieder N; Institute of Virology, Freie Universität Berlin, Berlin, Germany.; Department of Infectious Disease and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.
Sigal M; Department of Hepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Pokaż więcej
Źródło :
EMBO molecular medicine [EMBO Mol Med] 2021 Apr 09; Vol. 13 (4), pp. e13191. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Journal Article
MeSH Terms :
Models, Immunological*
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
SARS-CoV-2*/pathogenicity
COVID-19/*etiology
Interferon-gamma/*immunology
Angiotensin-Converting Enzyme 2/genetics ; Angiotensin-Converting Enzyme 2/metabolism ; Animals ; COVID-19/immunology ; COVID-19/pathology ; Cell Differentiation/immunology ; Colon/immunology ; Colon/pathology ; Colon/virology ; Disease Susceptibility ; Enterocytes/metabolism ; Enterocytes/pathology ; Enterocytes/virology ; Gene Expression ; Host Microbial Interactions/immunology ; Humans ; Interferon-gamma/administration & dosage ; Intestinal Mucosa/immunology ; Intestinal Mucosa/pathology ; Intestinal Mucosa/virology ; Mice ; Organoids/immunology ; Organoids/pathology ; Organoids/virology ; Virus Replication/immunology
Czasopismo naukowe
Tytuł :
[Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Autorzy :
Costa Frossard-França L; Hospital Universitario Ramón y Cajal, Madrid, España.
García-Domínguez JM; Hospital Universitario Gregorio Marañón, Madrid, España.
Moreno-Torres I; Hospital Universitario Fundación Jiménez Díaz, Madrid, España.
Fortún J; Hospital Universitario Ramón y Cajal, 28034 Madrid, España.
Villar LM; Hospital Universitario Ramón y Cajal, Madrid, España.
Meca-Lallana V; Hospital Universitario La Princesa, Madrid, España.
Pokaż więcej
Transliterated Title :
Vacunación frente al SARS-CoV-2 en pacientes con esclerosis múltiple.
Źródło :
Revista de neurologia [Rev Neurol] 2021 Apr 01; Vol. 72 (7), pp. 250-260.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Vaccination*/adverse effects
COVID-19/*prevention & control
Immunosuppressive Agents/*adverse effects
Multiple Sclerosis/*immunology
SARS-CoV-2/*immunology
Antibodies, Viral/biosynthesis ; Antibody Formation/drug effects ; COVID-19/immunology ; Communicable Disease Control/methods ; Humans ; Immunization Schedule ; Immunocompromised Host ; Immunogenicity, Vaccine ; Immunosuppressive Agents/pharmacology ; Immunosuppressive Agents/therapeutic use ; Influenza Vaccines/administration & dosage ; Masks ; Multiple Sclerosis/drug therapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies